EUVIMEDEUVIMED entdecken
Crossref

Propranolol attenuates systemic inflammatory response in aged traumatic brain injury patients

Yongqi Zhu, Zhichao Lu, Chenxing Wang, Xingjia Zhu, Jiahua Qu, Rui Jiang, Peipei Gong, Wei Shi, Qianqian Liu

International Immunopharmacology · 2026

DOI: 10.1016/j.intimp.2026.117196 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2026. Verfasst von Yongqi Zhu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, Jiangsu 226001, China; Research…. Hauptthemen laut MEDLINE: Propranolol, Brain Injuries, Traumatic, Aging, Adrenergic beta-Antagonists. Die Arbeit nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Graduate Research and Innovation Projects of Jiangsu Province, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aged traumatic brain injury (TBI) patients typically have a worse prognosis than younger individuals, though the underlying mechanisms remain incompletely understood. Secondary neuroinflammation is a key determinant of outcomes following TBI, but how aging reshapes the neuroinflammatory response post-TBI remains poorly understood. Propranolol, a clinically available non-selective beta-adrenergic receptor blocker, has garnered increasing interest for its potential therapeutic value in TBI management. Published clinical studies have shown that early administration of propranolol reduces mortality, shortens hospital stays, and improves outcomes in patients with moderate-to-severe TBI. However, its effects and underlying mechanisms in aged patients remain unclear. Here, we investigated the regulatory mechanisms by which propranolol modulates systemic inflammatory responses in aged TBI mice and conducted a retrospective exposure-based clinical cohort study enrolling aged TBI patients. We found that propranolol significantly reduced the production of peripheral blood-derived neutrophils and classical monocytes, and inhibited their infiltration into the brain. In contrast, both peripheral and brain-infiltrating non-classical monocyte populations were expanded. Mechanistically, propranolol substantially reversed the inflammatory transcriptomic profiles in both the bone marrow and brain of aged TBI mice, as evidenced by the downregulation of myeloid cell differentiation and inflammation-related signaling pathways. Behavioral outcomes of aged TBI mice were also significantly improved. It is worth noting that transcriptomic analysis of patient-derived peripheral blood mononuclear cells (PBMCs) and proteomic analysis of cerebrospinal fluid (CSF) also indicated that systemic inflammatory responses are attenuated in aged TBI patients treated with propranolol. In summary, our study suggests that propranolol holds significant clinical potential for alleviating systemic inflammation and improving outcomes in aged TBI patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PropranololBrain Injuries, TraumaticAgingAdrenergic beta-AntagonistsAnti-Inflammatory AgentsSystemic Inflammatory Response SyndromeAnimalsHumansMaleMiceAgedFemaleMice, Inbred C57BLRetrospective StudiesBrainInflammationDisease Models, AnimalMiddle AgedNeutrophils

Stichwörter der Autor:innen

ImmunityNeuroinflammationPropranololTraumatic brain injury

Substanzen

PropranololAdrenergic beta-AntagonistsAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Neurosurgery, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, Jiangsu 226001, China; Research Center of Clinical Medicine, Affiliated Hospital of Nantong Universit…
  • Department of Neurosurgery, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, Jiangsu 226001, China.
  • Department of Neurosurgery, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, Jiangsu 226001, China. Electronic address: ntgpp@ntu.edu.cn.
  • Department of Neurosurgery, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, Jiangsu 226001, China. Electronic address: fysw@ntu.edu.cn.
  • Department of Neurosurgery, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, Jiangsu 226001, China. Electronic address: ntfyliuqianqian@163.com.

Förderung

  • National Natural Science Foundation of China
  • Graduate Research and Innovation Projects of Jiangsu Province
  • National Key Research and Development Program of China
  • Key Technologies Research and Development Program

Zitieren

APA

Zhu, Y., Lu, Z., Wang, C., Zhu, X., Qu, J., Jiang, R., Gong, P., Shi, W., & Liu, Q. (2026). Propranolol attenuates systemic inflammatory response in aged traumatic brain injury patients. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2026.117196

Vancouver

Zhu Y, Lu Z, Wang C, Zhu X, Qu J, Jiang R, et al. Propranolol attenuates systemic inflammatory response in aged traumatic brain injury patients. International Immunopharmacology. 2026. doi:10.1016/j.intimp.2026.117196

BibTeX
@article{Zhu2026,
  author = {Zhu, Yongqi and Lu, Zhichao and Wang, Chenxing and Zhu, Xingjia and Qu, Jiahua and Jiang, Rui and Gong, Peipei and Shi, Wei and Liu, Qianqian},
  title = {Propranolol attenuates systemic inflammatory response in aged traumatic brain injury patients},
  journal = {International Immunopharmacology},
  year = {2026},
  doi = {10.1016/j.intimp.2026.117196}
}
Kostenlos starten →